This webinar reviews the current status of CAR NK cell-based immunotherapy. Martha Elia Luevano Salinas, global product manager of NK cells at Miltenyi Biotec, discusses the following topics:
About the presenter
Martha completed her postdoctoral research in stem cells (Miltenyi Biotec-Marie Curie fellowship) and her Ph.D. at the Anthony Nolan Institute (University College London), finding solutions to expand NK cells for therapeutic purposes. Her combined experience in molecular and cellular research has made her the recipient of international grants and fellowships.